Comparison between Aatmaj Healthcare IPO and Cell Point IPO.
Aatmaj Healthcare IPO is a SME Fixed Price IPO proposed to list at NSE SME while Cell Point IPO is a SME Fixed Price proposed to list at NSE SME.
| Aatmaj Healthcare IPO | Cell Point IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Nirbhay Capital Services Pvt.Ltd. | First Overseas Capital Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Rikhav Securities Ltd. | NNM Securities Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aatmaj Healthcare IPO is up to ₹36.47 Cr whereas the issue size of the Cell Point IPO is up to ₹47.82 Cr. The final issue price of Aatmaj Healthcare IPO is ₹60.00 per share and of Cell Point IPO is ₹100.00 per share.
| Aatmaj Healthcare IPO | Cell Point IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹60.00 per share | ₹100.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1200 shares |
| Fresh Issue Size | 60,78,000 shares | 47,82,000 shares |
| Fresh Issue Size (Amount) | up to ₹36.47 Cr | up to ₹47.82 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 60,78,000 shares | 47,82,000 shares |
| Issue Size Total (Amount) | up to ₹36.47 Cr | up to ₹47.82 Cr |
Aatmaj Healthcare IPO opens on Jun 19, 2023, while Cell Point IPO opens on Jun 15, 2023. The closing date of Aatmaj Healthcare IPO and Cell Point IPO is Jun 21, 2023, and Jun 20, 2023, respectively.
| Aatmaj Healthcare IPO | Cell Point IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 19, 2023 | Jun 15, 2023 |
| Issue Close | Jun 21, 2023 | Jun 20, 2023 |
| Basis Of Allotment (Tentative) | Jun 26, 2023 | Jun 23, 2023 |
| Initiation of Refunds (Tentative) | Jun 27, 2023 | Jun 26, 2023 |
| Credit of Share (Tentative) | Jun 29, 2023 | Jun 27, 2023 |
| Listing date (Tentative) | Jun 30, 2023 | Jun 28, 2023 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Aatmaj Healthcare IPO P/E ratio is 17.6, as compared to Cell Point IPO P/E ratio of 24.1.
| Aatmaj Healthcare IPO | Cell Point IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 88.89 | 100.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 63.72 | 73.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 17.6 | 24.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹135.60 Cr. | ₹186.86 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 69.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.41 | ₹11.60 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 60.68 | 10.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aatmaj Healthcare IPO Retail Individual Investors (RII) are offered 30,39,500 shares while in Cell Point IPO retail investors are offered 30,39,500 shares. Qualified Institutional Buyers (QIB) are offered in Aatmaj Healthcare IPO and in Cell Point IPO.
| Aatmaj Healthcare IPO | Cell Point IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 3,22,000 shares | 2,52,000 shares |
| QIB | ||
| NII | 30,39,500 shares | 23,91,000 shares |
| RII | 30,39,500 shares | 23,91,000 shares |
| Employee | ||
| Others | ||
| Total | 60,79,000 shares | 47,82,000 shares |
Aatmaj Healthcare IPO subscribed 33.60x in total, whereas Cell Point IPO subscribed 6.03x.
| Aatmaj Healthcare IPO | Cell Point IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 36.78x | 4.11x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 30.27x | 7.92x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 33.60x | 6.03x |
